|
Glioblastoma and Other Malignant Gliomas: A Clinical Review
|
journal
|
November 2013 |
|
The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft-Matter Nanorods
|
journal
|
January 2015 |
|
Genome-Free Viral Capsids as Multivalent Carriers for Taxol Delivery
|
journal
|
November 2009 |
|
Enhancing Antibody Response against Small Molecular Hapten with Tobacco Mosaic Virus as a Polyvalent Carrier
|
journal
|
May 2015 |
|
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
|
journal
|
April 2009 |
|
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
|
journal
|
May 2010 |
|
Polymeric anticancer drugs with pH-controlled activation
|
journal
|
June 2004 |
|
Transport of drugs across the blood–brain barrier by nanoparticles
|
journal
|
July 2012 |
|
Modeling the effects of vasculature evolution on early brain tumor growth
|
journal
|
December 2006 |
|
Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness
|
journal
|
April 2000 |
|
Stable Disk Assemblies of a Tobacco Mosaic Virus Mutant as Nanoscale Scaffolds for Applications in Drug Delivery
|
journal
|
September 2016 |
|
Biodistribution of Antibody-MS2 Viral Capsid Conjugates in Breast Cancer Models
|
journal
|
September 2016 |
|
Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy
|
journal
|
March 2016 |
|
Using Synthetically Modified Proteins to Make New Materials
|
journal
|
September 2011 |
|
Addition of sulfhydryl groups of Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate)
|
journal
|
December 1978 |
|
Glycan-Targeted Virus-like Nanoparticles for Photodynamic Therapy
|
journal
|
July 2012 |
|
Self-Assembling Light-Harvesting Systems from Synthetically Modified Tobacco Mosaic Virus Coat Proteins
|
journal
|
March 2007 |
|
P22 Viral Capsids as Nanocomposite High-Relaxivity MRI Contrast Agents
|
journal
|
July 2012 |
|
Increased Tumor Homing and Tissue Penetration of the Filamentous Plant Viral Nanoparticle Potato virus X
|
journal
|
July 2012 |
|
PET Imaging and Biodistribution of Chemically Modified Bacteriophage MS2
|
journal
|
November 2012 |
|
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
|
journal
|
April 2006 |
|
Host–guest encapsulation of materials by assembled virus protein cages
|
journal
|
May 1998 |
|
Gene therapy for human glioblastoma using neurotropic JC virus-like particles as a gene delivery vector
|
journal
|
February 2018 |
|
New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
|
journal
|
September 1999 |
|
A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells
|
journal
|
January 2013 |
|
Design of virus-based nanomaterials for medicine, biotechnology, and energy
|
journal
|
January 2016 |
|
The effect of particle design on cellular internalization pathways
|
journal
|
August 2008 |
|
Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms
|
journal
|
October 2013 |
|
Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors
|
journal
|
November 2016 |
|
Multivalent Viral Capsids with Internal Cargo for Fibrin Imaging
|
journal
|
June 2014 |
|
The blood-brain barrier: Bottleneck in brain drug development
|
journal
|
January 2005 |
|
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
|
journal
|
January 2003 |
|
Research Highlights: Highlights from the latest articles in nanomedicine
|
journal
|
March 2014 |
|
Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
|
journal
|
July 2010 |
|
Why one-size-fits-all vaso-modulatory interventions fail to control glioma invasion: in silico insights
|
preprint
|
January 2016 |
|
Glioblastoma and Other Malignant Gliomas: A Clinical Review
|
journal
|
November 2013 |
|
The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft-Matter Nanorods
|
journal
|
January 2015 |
|
Genome-Free Viral Capsids as Multivalent Carriers for Taxol Delivery
|
journal
|
November 2009 |
|
Genome-Free Viral Capsids as Multivalent Carriers for Taxol Delivery
|
journal
|
November 2009 |
|
Enhancing Antibody Response against Small Molecular Hapten with Tobacco Mosaic Virus as a Polyvalent Carrier
|
journal
|
May 2015 |
|
Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo
|
journal
|
November 2016 |
|
The blood-brain barrier: Bottleneck in brain drug development
|
journal
|
January 2005 |
|
Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness
|
journal
|
April 2000 |
|
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
|
journal
|
April 2009 |
|
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
|
journal
|
May 2010 |
|
The preferential targeting of the diseased microvasculature by disk-like particles
|
journal
|
August 2012 |
|
Plant viruses and bacteriophages for drug delivery in medicine and biotechnology
|
journal
|
June 2017 |
|
Polymeric anticancer drugs with pH-controlled activation
|
journal
|
June 2004 |
|
Transport of drugs across the blood–brain barrier by nanoparticles
|
journal
|
July 2012 |
|
Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy
|
journal
|
October 2016 |
|
Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy
|
journal
|
September 2018 |
|
Modeling the effects of vasculature evolution on early brain tumor growth
|
journal
|
December 2006 |
|
Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment
|
journal
|
February 2014 |
|
Stable Disk Assemblies of a Tobacco Mosaic Virus Mutant as Nanoscale Scaffolds for Applications in Drug Delivery
|
journal
|
September 2016 |
|
Diffusion and Uptake of Tobacco Mosaic Virus as Therapeutic Carrier in Tumor Tissue: Effect of Nanoparticle Aspect Ratio
|
journal
|
April 2016 |
|
Biodistribution of Antibody-MS2 Viral Capsid Conjugates in Breast Cancer Models
|
journal
|
September 2016 |
|
Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy
|
journal
|
March 2016 |
|
Using Synthetically Modified Proteins to Make New Materials
|
journal
|
September 2011 |
|
Addition of sulfhydryl groups of Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate)
|
journal
|
December 1978 |
|
Glycan-Targeted Virus-like Nanoparticles for Photodynamic Therapy
|
journal
|
July 2012 |
|
Dual-Surface Modification of the Tobacco Mosaic Virus
|
journal
|
March 2005 |
|
Self-Assembling Light-Harvesting Systems from Synthetically Modified Tobacco Mosaic Virus Coat Proteins
|
journal
|
March 2007 |
|
N-Terminal Modification of Proteins with o -Aminophenols
|
journal
|
June 2014 |
|
P22 Viral Capsids as Nanocomposite High-Relaxivity MRI Contrast Agents
|
journal
|
July 2012 |
|
Increased Tumor Homing and Tissue Penetration of the Filamentous Plant Viral Nanoparticle Potato virus X
|
journal
|
July 2012 |
|
PET Imaging and Biodistribution of Chemically Modified Bacteriophage MS2
|
journal
|
November 2012 |
|
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
|
journal
|
April 2006 |
|
Nanoscale Protein Assemblies from a Circular Permutant of the Tobacco Mosaic Virus
|
journal
|
January 2010 |
|
Host–guest encapsulation of materials by assembled virus protein cages
|
journal
|
May 1998 |
|
Nanoparticle-mediated cellular response is size-dependent
|
journal
|
March 2008 |
|
Gene therapy for human glioblastoma using neurotropic JC virus-like particles as a gene delivery vector
|
journal
|
February 2018 |
|
New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
|
journal
|
September 1999 |
|
Why one-size-fits-all vaso-modulatory interventions fail to control glioma invasion: in silico insights
|
journal
|
November 2016 |
|
Design of virus-based nanomaterials for medicine, biotechnology, and energy
|
journal
|
January 2016 |
|
A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells
|
journal
|
January 2013 |
|
The effect of particle design on cellular internalization pathways
|
journal
|
August 2008 |
|
Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms
|
journal
|
October 2013 |
|
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
|
journal
|
October 2013 |
|
Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors
|
journal
|
November 2016 |
|
Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts1
|
journal
|
January 2007 |
|
Multivalent Viral Capsids with Internal Cargo for Fibrin Imaging
|
journal
|
June 2014 |
|
The blood-brain barrier: Bottleneck in brain drug development
|
journal
|
January 2005 |
|
The effect of particle design on cellular internalization pathways
|
text
|
January 2008 |
|
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
|
journal
|
January 2003 |
|
Ff-nano, short functionalized nanorods derived from Ff (f1, fd, or M13) filamentous bacteriophage
|
journal
|
April 2015 |
|
Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
|
journal
|
January 2010 |